Company: SNWV
Filing Date: 2025-07-10
Form Type: DEF 14A
Source: 0001140361-25-025486
Chunk: 26

Company: SANUWAVE Health, Inc.
Filing Date: 2025-07-10
Form: DEF 14A
Chunk 26
---
 Date. Description of the 2024 Plan The major features of the 2024 Plan, as amended, are summarized below. The summary is qualified in its entirety by reference to the full text of the 2024 Plan, as amended, which is attached to this proxy statement as Appendix A. Administration The 2024 Plan is administered by our Compensation Committee (the “Plan Administrator”). Subject to the terms of the 2024 Plan, the Plan Administrator has the authority to (a) determine the eligible individuals who are to receive awards under the 2024 Plan, (b) determine the terms and conditions of awards granted under the 2024 Plan, (c) determine performance criteria and the achievement of such criteria, (d) cancel, suspend, or accelerate the vesting or exercisability of, payment for or lapse of restrictions on, or amend any other terms of awards, (e) adopt sub-plans,

17

TABLE OF CONTENTS (f) issue substitute awards, and (g) make all other decisions related to the 2024 Plan and awards granted thereunder. The Plan Administrator may also delegate to one or more of its members, a director or directors, or senior officers of the Company the authority to grant awards, subject to terms and conditions determined by the Plan Administrator and within the limitations of Section 16 of the Exchange Act. Types of Awards The 2024 Plan provides for the grant of stock options, which may be incentive stock options (“ISOs”) or nonstatutory stock options (“NSOs”), stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), and other equity-based or equity-related awards that the Plan Administrator determines are consistent with the purpose of the 2024 Plan and the interests of the Company, or collectively, awards. Share Reserve If the Amendment is approved by stockholders, the total number of shares which may be issued under the 2024 Plan would be increased by 500,000 shares of our common stock that may be issued under the 2024 Plan to a total of 1,876,556 shares. All of the shares available under the 2024 Plan may be issued upon the exercise of ISOs. If awards issued under the 2024 Plan, or awards issued under the 2006 Plan that were outstanding on the date our shareholders initially approved the 2024 Plan, are forfeited, cancelled, settled, or paid in cash, or expire before being exercised or settled in full, the shares subject to such awards